BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Eroglu E, Sipahioglu MH, Senel S, Ertas SK, Savas S, Ozturk F, Kocyigit I, Tokgoz B, Oymak O. Successful treatment of tubulointerstitial nephritis in immunoglobulin G4-related disease with rituximab: A case report. World J Clin Cases 2019; 7(16): 2309-2315 [PMID: 31531324 DOI: 10.12998/wjcc.v7.i16.2309]
URL: https://www.wjgnet.com/2307-8960/full/v7/i16/2309.htm
Number Citing Articles
1
Utkarsh Patel, Ayushi Saxena, Dhara Patel, Ismat E Ayesha, Neetha R Monson, Nimra Klair, Ann Kashmer Yu. Therapeutic Uses of Rituximab and Clinical Features in Immunoglobulin G4-Related Disease: A Systematic ReviewCureus 2023;  doi: 10.7759/cureus.45044
2
Zdeněk Adam, Milan Dastych, Aleš Čermák, Martina Doubková, Šárka Skorkovská, Luděk Pour, Zdeněk Řehák, Renata Koukalová, Zuzana Adamová, Martin Štork, Marta Krejčí, Ivanna Boichuk, Zdeněk Král. Therapy of immunoglonuline IgG4 related disease (IgG4-RD)Vnitřní lékařství 2022; 68(6): E15 doi: 10.36290/vnl.2022.086
3
Joel P. Russell, Helen Healy, Leo Francis, Julia Jefferis. Concurrent membranous nephropathy and allergic interstitial nephritis causing acute kidney injury—A case reportNephrology 2022; 27(7): 639 doi: 10.1111/nep.14021
4
O.B. Iaremenko, D.I. Koliadenko. IgG4-related kidney diseaseKIDNEYS 2021; 10(2): 114 doi: 10.22141/2307-1257.10.2.2021.234332